Article Details
Retrieved on: 2023-10-10 15:45:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical stage company developing telomere-targeting immunotherapies for cancer, announced today ...
Article found on: www.tullahomanews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here